Literature DB >> 15633220

TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway.

Mei Shi1, Xia Zhang, Ping Wang, Hong-Wei Zhang, Bai-He Zhang, Meng-Chao Wu.   

Abstract

AIM: To investigate the role of TIP30 in apoptotic signal pathway in hepatoblastoma cells and to provide a basis for TIP30 as a gene therapy candidate in the regression of hepatoblastoma cells.
METHODS: Apoptosis of human hepatoblastoma cell lines HepG2 (p53 wild), Hep3B (p53 null) and PLC/RPF/5 (p53 mutant) infected with Ad-TIP30 (bearing a wild type human Tip30 gene) were analyzed and p53, Bax and Bcl-xl expression levels were compared among these cells. MTT assay, DNA fragmentation, in situ 3' end labeling of DNA, annexin-V FITC staining were used to detect cell death and apoptosis in cells at various time intervals subsequent to infection, and to determine whether TIP30 had an effect on the expression levels of some apoptosis-related gene products such as Bax, p53 and Bcl-xl. A similar time course experiment was performed by Western blotting.
RESULTS: In MTT assay, the viability of HepG2 cells decreased significantly from 99.7% to 10% and displayed more massive cell death within 5-8 d than Hep3B and PLC/RPF/5 cells, with their viability decreased from 97.8% to 44.3% and 98.1% to 50.4%, respectively. In annexin-V FITC assay, the percentage of apoptosis cells in HepG2 cells was two to three-fold higher than that in control cells (infected with Ad-GFP), two-fold higher than that in Hep3B cells and 1.4-fold higher than that in PLC/RPF/5 cells 36 h after infection, respectively. Moreover, in HepG2 cells, the p53 began to increase 6-8 h after infection, reaching a maximum level between 8 and 12 h after infection and then dropped. Bax showed a similar increase in the cells as p53 reached the maximum at 8-12 h and subsequently decreased. Interestingly, Bcl-xl protein levels were down regulated during 24 to 36 h after Ad-TIP30 infection. In contrast, ectopic expression of TIP30 in Hep3B and PLC/RPF/5 cells had no effect on the regulation of Bax expression, but had an effect on Bcl-xl levels. In comparison with HepG2 cells, these data suggested that up-regulation of p53 levels by TIP30 might be a pre-requisite for Bax and Bax/Bcl-xl ratio increase. We hypothesized that TIP30 might regulate Bax gene partly through p53, which sensitizes cells to apoptosis by involving a p53 apoptosis signal transduction pathway.
CONCLUSION: TIP30 plays an important role in predisposing hepatoblastoma cells to apoptosis through regulating expression levels of these genes. Ad-TIP30 carrying exogenous TIP30-anti-tumor genes may be regarded as a potential candidate for the treatment of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15633220      PMCID: PMC4205406          DOI: 10.3748/wjg.v11.i2.221

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter.

Authors:  E C Thornborrow; J J Manfredi
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

2.  p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning.

Authors:  Mihaela M Mocanu; Derek M Yellon
Journal:  FEBS Lett       Date:  2003-12-04       Impact factor: 4.124

3.  Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.

Authors:  M C Jiang; H F Yang-Yen; J K Lin; J J Yen
Journal:  Oncogene       Date:  1996-08-01       Impact factor: 9.867

4.  Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma.

Authors:  I Mohiuddin; X Cao; B Fang; M Nishizaki; W R Smythe
Journal:  Cancer Gene Ther       Date:  2001-08       Impact factor: 5.987

Review 5.  Protein p53--structure, function, and possible therapeutic implications.

Authors:  Tanja Batinac; Franjo Gruber; Jasna Lipozencić; Gordana Zamolo-Koncar; Adalbert Stasić; Ines Brajac
Journal:  Acta Dermatovenerol Croat       Date:  2003-12       Impact factor: 1.256

6.  Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.

Authors:  Yan-Nian Chen; Jung-Chou Chen; Sui-Chu Yin; Guang-Sheng Wang; Wei Tsauer; Sheng-Feng Hsu; Shih-Lan Hsu
Journal:  Int J Cancer       Date:  2002-07-10       Impact factor: 7.396

7.  Molecular markers in breast cancer: can we use c-erbB-2, p53, bcl-2 and bax gene expression as prognostic factors?

Authors:  Constantine Dimitrakakis; Manousos Konstadoulakis; Evangelos Messaris; George Kymionis; Maria Karayannis; Dimitrios Panoussopoulos; Stylianos Michalas; George Androulakis
Journal:  Breast       Date:  2002-08       Impact factor: 4.380

8.  Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.

Authors:  Philipp G Hemmati; Bernhard Gillissen; Clarissa von Haefen; Jana Wendt; Lilian Stärck; Dilek Güner; Bernd Dörken; Peter T Daniel
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

9.  Sox-4 is a positive regulator of Hep3B and HepG2 cells' apoptosis induced by prostaglandin (PG)A(2) and delta(12)-PGJ(2).

Authors:  Sang-Gun Ahn; Ho-Shik Kim; Seong-Whan Jeong; Bo-Eun Kim; Hyangshuk Rhim; Jae-Yong Shim; Jin-Woo Kim; Jeong-Hwa Lee; In-Kyung Kim
Journal:  Exp Mol Med       Date:  2002-07-31       Impact factor: 8.718

10.  Synergetic anticancer effect of combined quercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro.

Authors:  Ming Shi; Fu-Sheng Wang; Zu-Ze Wu
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

View more
  9 in total

1.  Modification of gene expression of the small airway epithelium in response to cigarette smoking.

Authors:  Ben-Gary Harvey; Adriana Heguy; Philip L Leopold; Brendan J Carolan; Barbara Ferris; Ronald G Crystal
Journal:  J Mol Med (Berl)       Date:  2006-11-08       Impact factor: 4.599

2.  Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinoma.

Authors:  Jianqiu Chen; Chunsheng Zhu; Minhui Zhu; Ming Geng; Yongsheng Tian; Guojun Li; Hongliang Zheng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

3.  Expression of TIP30 tumor suppressor gene is down-regulated in human colorectal carcinoma.

Authors:  Xiaobing Chen; Xinguang Cao; Wenjie Dong; Suxia Luo; Zhenhe Suo; Yinchun Jin
Journal:  Dig Dis Sci       Date:  2009-10-03       Impact factor: 3.199

4.  TIP30 directly binds p53 tumor suppressor protein in vitro.

Authors:  Si-Hyung Lee; Sung-Kyu Ju; Tae-Young Lee; Sung-Ho Huh; Kyou-Hoon Han
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

5.  High serum HTATIP2/TIP30 level in serous ovarian cancer as prognostic or diagnostic marker.

Authors:  Yakup Kumtepe; Zekai Halici; Ozlem Sengul; Celalettin Semih Kunak; Yasin Bayir; Nergiz Kilic; Elif Cadirci; Alparslan Pulur; Zafer Bayraktutan
Journal:  Eur J Med Res       Date:  2013-06-24       Impact factor: 2.175

6.  Overexpression of TIP30 inhibits the growth and invasion of glioma cells.

Authors:  Yingying Hu; Fengsheng Chen; Feiye Liu; Xinhui Liu; Na Huang; Xiaoli Cai; Yi Sun; Aimin Li; Rongcheng Luo
Journal:  Mol Med Rep       Date:  2015-11-27       Impact factor: 2.952

7.  Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.

Authors:  Tao Xu; Zhichao Jin; Yuan Yuan; Honggang Zheng; Conghuang Li; Wei Hou; Qiujun Guo; Baojin Hua
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

8.  TIP30 regulates lipid metabolism in hepatocellular carcinoma by regulating SREBP1 through the Akt/mTOR signaling pathway.

Authors:  F Yin; G Sharen; F Yuan; Y Peng; R Chen; X Zhou; H Wei; B Li; W Jing; J Zhao
Journal:  Oncogenesis       Date:  2017-06-12       Impact factor: 7.485

9.  Absence of HTATIP2 Expression in A549 Lung Adenocarcinoma Cells Promotes Tumor Plasticity in Response to Hypoxic Stress.

Authors:  Minghua Li; Jing Li; Xiaofang Guo; Hua Pan; Qingyu Zhou
Journal:  Cancers (Basel)       Date:  2020-06-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.